Zuhal Atan UÇAR
(İstanbul Bilim Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, İstanbul, Türkiye)
Yener KOÇ
(İstanbul Bilim Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, İstanbul, Türkiye)
Taner BAŞTÜRK
(Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, İstanbul, Türkiye)
Feyza BAYRAKTAR ÇAĞLAYAN
(Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, İstanbul, Türkiye)
Tamer SAKACI
(Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, İstanbul, Türkiye)
Elbis AHBAP
(Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, İstanbul, Türkiye)
Ayşe SİNANGİL
(İstanbul Bilim Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Nefroloji Bilim Dalı, İstanbul, Türkiye)
Mustafa SEVİNÇ
(Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, İstanbul, Türkiye)
Arzu KAYALAR
(Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, İstanbul, Türkiye)
Nuri Barış HASBAL
(Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, İstanbul, Türkiye)
Abdülkadir ÜNSAL
(Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi, Nefroloji Kliniği, İstanbul, Türkiye)
Yıl: 2019Cilt: 28Sayı: 1ISSN: 1300-7718 / 2667-4440Sayfa Aralığı: 54 - 61İngilizce

27 0
The Impact of Peritonitis on Clinical Outcomes of PD Patients: A Single Center Experience
Objective: The aim of the present study was to investigate peritonitis episodes and causative agents in patients undergoing peritoneal dialysis (PD), to examine the effects of peritonitis on technical and patient survival, and to determine whether the number of peritonitis episodes and causative agents was a risk factor or not. Materials and Methods: The medical records of 387 patients who started PD between January 2001 and January 2015 were evaluated retrospectively. Patients without peritonitis (Group 1 (n=123 patients)) and with detected peritonitis (Group 2 (n=243 patients)) were divided into two groups. Group 2 patients were subdivided according to the number of peritonitis (Group 2a 1 episode and Group 2b ≥2 episodes). Sociodemographic data and clinical courses were compared, and the reasons for PD withdrawal were obtained between the groups. Survival analysis was performed, and the effects of peritonitis on mortality were investigated. Results: A total of 427 peritonitis episodes were detected. The most common organism was Staphylococcus aureus (36%). The leading cause of death was cardiovascular disease in Group 1, whereas it was infection in Group 2a and Group 2b. Technique survival and mortality rates were similar among the groups. Risk factors for patient survival were history of peritonitis more than once and history of catheter exit site/tunnel infection. History of catheter exit site/tunnel infection was the only risk factor for technique survival. Conclusion: Our study has shown that even though the causes for mortality were different, mortality rates, and technique survival were similar between the two main groups. Infectious complications may affect patient and technical survival.
DergiAraştırma MakalesiErişime Açık
  • 1. Kotsanas D, Polkinghorne KR, Korman TM, Atkins RC, Brown F. Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selec-tion? Nephrology (Carlton) 2007; 12: 239-45. [CrossRef]
  • 2. Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001; 16: 341-7. [CrossRef]
  • 3. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al. ISPD Peritonitis recomendations: 2016 update on prevention and treatment. Perit Dial Int 2016, 36: 481-508. [CrossRef]
  • 4. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its im-pact on patient survival. Perit Dial Int 1997; 17: 360-4.
  • 5. Rojas-Campos E, Alcántar-Medina M, Cortés-Sanabria L, MartínezRamírez HR, Camarena JL, Chávez S, et al. Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico. Rev Invest Clin 2007; 59: 184-91.
  • 6. Hsieh YP, Chang CC, Wen YK, Chiu PF, Yang Y. Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Tai-wan-10 years’ experience in a single center. Perit Dial Int 2014; 34: 85-94. [CrossRef]
  • 7. Hsieh YP, Chang CC, Wang SC, Wen YK, Chiu PF, Yang Y. Predictors for and impact of high peritonitis rate in Taiwanese continuous ambulatory peritoneal dialysis patients. Int Urol Nephrol 2015; 47: 183-9. [CrossRef]
  • 8. Brown MC, Simpson K, Kerssens JJ, Mactier RA, Scottish Renal Registry. Peritoneal dialysis associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007). Perit Dial Int 2011; 31: 639-50. [CrossRef]
  • 9. Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, et al. Mi-crobiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 2011; 31: 651-62. [CrossRef]
  • 10. Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int 2009; 29: 297-302.
  • 11. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Are peritoneal dialysispatients with and without residual renal function equivalent for survival study? Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 2003; 18: 977-82. [CrossRef]
  • 12. Boudville N, Kemp A, Clayton P, Lim W, Badve SV, Hawley CM, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol 2012; 23: 1398-405. [CrossRef]
  • 13. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialy-sis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52: 524-9. [CrossRef]
  • 14. Pérez Fontan M, Rodríguez-Carmona A, García-Naveiro R, Rosales M, Villaverde P, Valdés F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25: 274- 84.
  • 15. Kim DK, Yoo TH, Ryu DR. Changes in causative organisms and their antimicrobial susceptibili-ties in CAPD peritonitis: a single center’s experience over one decade. Perit Dial Int 2004; 24: 424-32.
  • 16. Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004; 19: 2584-91. [CrossRef]
  • 17. Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, et al. Improv-ing outcome of CAPD:twenty-five years’ experience in a single Korean center. Perit Dial Int 2007; 27: 432-40.
  • 18. Lai KN, Lo WK. Optimal peritoneal dialysis for patients from Hong Kong. Perit Dial Int 1999; 19: S26-31.
  • 19. Lo WK, Jiang Y, Cheng SW, Cheng IKP. Survival of CAPD patients in a center using three two-liter exchanges as standard regime. Perit Dial Int 1996; 16: S163-6.
  • 20. Gamba G, Mejia JL, Saldivar S, Pena JC, Correa-Rotter R. Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron 1993; 65: 23-7. [CrossRef]
  • 21. Cueto-Manzano AM, Quintana-Pina E, Correa-Rotter R. Long-term CAPD survival and analy-sis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int 2001; 21: 148-53.
  • 22. Smit W, Parikova A, Krediet RT. Ultrafiltration failure in peritoneal dialysis. Causes and clini-cal consequences. Minerva Urol Nefrol 2005; 57: 165-74.
  • 23. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al. Mortality risks of peri-toneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065-74. [CrossRef]
  • 24. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peri-toneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9: 1285-92.
  • 25. Johnson JG, Gore SM, Firth J. The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: A systematic quantitative overview of the literature. Nephrol Dial Transplant 1999; 14: 2156-64. [CrossRef]
  • 26. Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis-associated peritonitis in scotland (1999-2002). Nephrol Dial Transplant 2004; 19: 2584-91. [CrossRef]
  • 27. Mizuno M, Ito Y, Tanaka A, Suzuki Y, Hiramatsu H, Watanabe M, et al. Peritonitis is still an important factor for with-drawal from peritoneal dialysis therapy in the tokai area of Japan. Clin Exp Nephrol 2011; 15: 727-37. [CrossRef]
  • 28. Fourtounas C, Savidaki E, Dousdabanis P, Hardalias A, Kalliakmani P, Papachristou E, et al. Peritonitis during the first year after com-mencement of peritoneal dialysis has an impact on technique survival and patient morbidity. Adv Perit Dial 2006; 22: 50-4.
  • 29. Daly C, Cody JD, Khan I, Rabindranath KS, Vale L, Wallace SA. Double bag or y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kid-ney disease. Cochrane Database Syst Rev 2014; 8: CD003078.
  • 30. Boeschoten EW, Ter Wee PM, Divino J. Peritoneal dialysis-related infections recommenda-tions 2005-an important tool for quality improvement. Nephrol Dial Transplant 2006; 21 Suppl 2: ii31-33. [CrossRef]
  • 31. Isla RA, Mapiye D, Swanepoel CR, Rozumyk N, Hubahib JE, Okpechi IG. Continuous ambula-tory peritoneal dialysis in limpopo province, south africa: Predictors of patient and tech-nique survival. Perit Dial Int 2014; 34: 518-25. [CrossRef]
  • 32. Wang Z, Jiang L, Feng S, Yang L, Jiang S, Zhan Z, et al. Early peritonitis is an inde-pendent risk factor for mortality in elderly peritoneal dialysis patients. Kidney Blood Press Res 2015; 40: 298-305. [CrossRef]
  • 33. Culleton BF, Hemmelgarn BR. Is chronic kidney disease a cardiovascular disease risk factor?. Semin Dial 2003; 16: 95-100. [CrossRef]
  • 34. Shiao CC, Kao TW, Hung KY, Chen YC, Wu MS, Chu TS, et al. Seven-year follow-up of peritoneal dialysis patients in Taiwan. Perit Dial Int 2009; 29: 450-7.
  • 35. Unsal A, Koc Y, Basturk T, Sakaci T, Ahbap E, Sinangil A, et al. Clinical outcomes and mortality in peritoneal dialysis patients: a 10- year retrospective analysis in a single center. Clin Nephrol 2013; 80: 270-9. [CrossRef]
  • 36. Naz H, Sahin G, Serbest S, Yalcin AU. Peritonitis related to peritoneal dialysis: evaluation of 179 attacks. Mikrobiyol Bul 2008: 42: 265-72.
  • 37. Szeto CC, Wong TY, Chow KM, Leung CB, Law MC, Li PK. Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients. Perit Dial Int 2004; 24: 58-64.
  • 38. Miguel A, García R, Torregrosa I. Morbimortalidad en diálisis peritoneal continua ambulatoria (DPCA): Siete a-os de experiencia. Nefrologia 1997; 17: 233-40.
  • 39. Coronel F, Cigarrán S, Herrero JA. [Morbidity and mortality in diabetic patients on peritoneal dialysis. Twenty-five years of experience at a single centre]. Nefrologia 2010; 30: 626-32.
  • 40. Muñoz de Bustillo E, Borrás F, Gómez-Roldán C, Pérez-Contreras FJ, Olivares J, García R, et al. Impact of peritonitis on long-term survival of peritoneal dialysis patients. Nefrologia 2011; 31: 723- 32.
  • 41. van Diepen AT, Tomlinson GA, Jassal SV. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol 2012; 7: 1266-71. [CrossRef]
  • 42. Yang CY, Chen TW, Lin YP, Lin CC, Ng YY, Yang WC, et al. Determinants of catheter loss following continuous ambulatory peritoneal dialysis peritonitis. Perit Dial Int 2008; 28: 361-70.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.